AI Antibody Humanization & Optimization

About ProteoGenix

ProteoGenix is a well-established, revenue-generating French biotech service provider with a core focus on antibody discovery and bioproduction. It differentiates itself by integrating proprietary AI-driven platforms for antibody humanization, affinity maturation, and developability assessment into its service offerings, aiming to accelerate client projects from research to clinic. With a broad portfolio spanning custom services for therapeutic and diagnostic developers and a large catalog of research reagents, the company operates globally, supporting both early-stage innovation and commercial product development. Its business is primarily service-based, with additional revenue from product sales.

Therapeutic Areas

Other Client-specific Drugs